天麻钩藤饮加减治疗高血压眩晕患者的临床效果

来源 :中国药物经济学 | 被引量 : 0次 | 上传用户:runzhong
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨天麻钩藤饮加减治疗高血压眩晕患者的临床效果。方法选取2014年2月至2015年6月北京市平谷区兴谷街道社区卫生服务中心金乡社区卫生服务站收治的48例高血压晕眩患者作为研究对象,其中23例服用硝苯地平片及卡托普利片治疗的患者设为对照组;另外25例应用天麻钩藤饮加减法治疗的患者设为观察组。比较两组患者治疗前后血压变化情况以及临床疗效。结果治疗后,两组患者的收缩压和舒张压均明显低于治疗前,且观察组患者的收缩压和舒张压均明显低于对照组,差异均有统计学意义(均P<0.05);观察组患者治疗的总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论天麻钩藤饮加减治疗高血压眩晕患者具有快速降压的效果,同时可提高临床疗效,减轻患者痛苦,降低不良反应发生。 Objective To investigate the clinical effects of Tianma Gouteng Decoction on patients with hypertensive vertigo. Methods Forty-eight patients with hypertensive vertigo were selected from Jinxun Community Health Service Station, Xinggu Sub-district Community Health Service Center, Xinggu Street, Pinggu District, Beijing from February 2014 to June 2015. Twenty-three of the patients took nifedipine tablets and Captopril tablets treated patients as the control group; the other 25 cases treated with Tianma Gouteng Decoction treatment of patients as the observation group. The changes of blood pressure before and after treatment and the clinical curative effect were compared between the two groups. Results After treatment, the systolic and diastolic blood pressures in both groups were significantly lower than those before treatment, and the systolic and diastolic blood pressures in the observation group were significantly lower than those in the control group (all P <0.05). The total effective rate of observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Conclusion Tianma Goutengyin treatment of hypertensive patients with vertigo has a rapid antihypertensive effect, while improving clinical efficacy, reduce patient pain and reduce adverse reactions.
其他文献
目的分析颅内孤立性纤维瘤(ISFT)的MRI表现。方法对经临床手术病理证实的4例ISFT的MRI表现进行回顾性分析。结果MRI影像显示4例均为不规则分叶状肿块,边界清;肿块均位于幕上,额顶部2例,额部跨中线1例,枕部跨中线1例。MRI平扫T1WI 4例均为等、略低信号为主,其中1例内见新月形高信号;2例T2WI以长T2信号为主,2例T2WI内见稍高、低混杂信号影,形成"阴阳"征;4例肿块FLAIR
期刊
@@
目的观察强化生活方式干预联合厄贝沙坦对早期2型糖尿病肾病的治疗效果。方法选择血压在正常范围的早期2型糖尿病肾病患者80例,随机数字表达法分为两组,在维持原糖尿病治疗方案同时,对照组40例给予口服厄贝沙坦片150 mg/d;治疗组40例在对照组治疗基础上予以强化生活方式干预,比较两组治疗前后的各项生化指标。结果经6个月治疗后,治疗组尿蛋白排泄率(UAER)、尿微量白蛋白/尿肌酐比值(UmAlb/C)
期刊
@@